1. Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma
   Xinyao Hu et al, 2022, Frontiers in Genetics CrossRef
2. Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells
   Qiuyue Zhang et al, 2023, Exploration of Targeted Anti-tumor Therapy CrossRef
3. Increased Expression of NXPH4 Correlates with Immune Cell Infiltration and Unfavorable Prognosis in Hepatocellular Carcinoma
   Qin Tang et al, 2022, Journal of Oncology CrossRef
4. The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals
   Rixiong Wang et al, 2022, Journal of Cancer Research and Clinical Oncology CrossRef
5. Prognostic and Immunological Significance of FUNDC1 in Hepatocellular Carcinoma: A Study on TCGA Mining
   Yuyin Le et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
6. Downstaging of advanced hepatocellular carcinoma followed by liver transplantation using immune checkpoint inhibitors: Where do we stand?
   Hirak Pahari et al, 2024, World Journal of Gastrointestinal Pharmacology and Therapeutics CrossRef